The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...

Michigan lawmakers plan to save money in the state's Medicaid program by limiting the use of popular weight loss drugs to ...

The basic principle of weight loss is straightforward: if you consume fewer calories than you burn, you'll lose weight. In ...

A NEW test that can help predict how people will respond to weight loss medications has been developed. It suggests that certain eaters may get on better with fat jabs. The test estimates an ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat healthily and exercise regularly. Injectable weight loss medications — also ...

Saxenda (liraglutide) is a GLP-1 agonist injection pen medication used to support long-term weight loss in adults with obesity, adults with overweight and weight-related health issues, and certain ...

Novo Nordisk, which lobbied to win Medicaid reimbursement for its obesity drug Wegovy, is fighting to keep that coverage as ...

Generic Saxenda ® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s ...

SNS Insider projects the global Weight Loss Drugs Market to grow from USD 2.76 Billion in 2024 to USD 50.26 Billion by 2032, at a CAGR of 43.73%.Austin, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Weight Loss ...

Centrally acting agents like phentermine/topiramate and naltrexone/bupropion aid weight reduction but lack MASLD-specific ...